Citation: J. Reinsberg, INTERFERENCES WITH 2-SITE IMMUNOASSAYS BY HUMAN ANTI-MOUSE ANTIBODIESFORMED BY PATIENTS TREATED WITH MONOCLONAL-ANTIBODIES - COMPARISON OFDIFFERENT BLOCKING REAGENTS, Clinical chemistry, 44(8), 1998, pp. 1742-1744
Authors:
SCHMOLLING J
REINSBERG J
WAGNER U
KREBS D
Citation: J. Schmolling et al., ANTI-TAG-72 ANTIBODY B72.3 - IMMUNOLOGICAL AND CLINICAL EFFECTS IN OVARIAN-CARCINOMA, Hybridoma, 16(1), 1997, pp. 53-58
Citation: J. Reinsberg et D. Krebs, ARE HUMAN ANTIIDIOTYPIC ANTI-OC125 ANTIBODIES FORMED AFTER IMMUNIZATION WITH THE ANTI-CA125 ANTIBODY B43.13, Hybridoma, 16(1), 1997, pp. 59-63
Authors:
SCHMOLLING J
JUNG S
REINSBERG J
SCHLEBUSCH H
Citation: J. Schmolling et al., DIFFUSION CHARACTERISTICS OF PLACENTAL PREPARATIONS AFFECT THE DIGOXIN PASSAGE ACROSS THE ISOLATED PLACENTAL LOBULE, Therapeutic drug monitoring, 19(1), 1997, pp. 11-16
Citation: J. Reinsberg et al., PERFORMANCE OF THE FULLY AUTOMATED PROGESTERONE ASSAYS ON THE ABBOTT AXSYM(R) AND THE TECHNICON-IMMUNO-1(R) ANALYZER COMPARED WITH THE RADIOIMMUNOASSAY PROGESTERONE MAIA(R), Clinical biochemistry, 30(6), 1997, pp. 469-471
Authors:
SCHMOLLING J
JUNG S
REINSBERG J
SCHLEBUSCH H
Citation: J. Schmolling et al., DIGOXIN TRANSFER ACROSS THE ISOLATED PLACENTA IS INFLUENCED BY MATERNAL AND FETAL ALBUMIN CONCENTRATIONS, Reproduction, fertility and development, 8(6), 1996, pp. 969-974
Citation: J. Reinsberg et al., A SIMPLE AND SENSITIVE ASSAY FOR DETERMINATION OF HUMAN ANTIIDIOTYPICANTI-B72.3 ANTIBODIES, WHICH IS NOT AFFECTED BY THE PRESENCE OF TUMOR-ASSOCIATED GLYCOPROTEIN-72, European journal of clinical chemistry and clinical biochemistry, 34(3), 1996, pp. 237-244
Citation: J. Reinsberg, DIFFERENT EFFICACY OF VARIOUS BLOCKING REAGENTS TO ELIMINATE INTERFERENCES BY HUMAN ANTIMOUSE ANTIBODIES WITH A 2-SITE IMMUNOASSAY, Clinical biochemistry, 29(2), 1996, pp. 145-148
Authors:
WEIMANN E
REISBACH G
REINSBERG J
LENTZE MJ
Citation: E. Weimann et al., IL-6 AND G-CSF LEVELS IN AMNIOTIC-FLUID DURING THE 2ND-TRIMESTER IN NORMAL AND ABNORMAL PREGNANCIES, Archives of gynecology and obstetrics, 256(3), 1995, pp. 125-130
Authors:
SCHMOLLING J
REINSBERG J
WAGNER U
KREBS D
Citation: J. Schmolling et al., ANTIIDIOTYPIC ANTIBODIES IN OVARIAN-CANCER PATIENTS TREATED WITH THE MONOCLONAL-ANTIBODY B72.3, Hybridoma, 14(2), 1995, pp. 183-186
Authors:
SCHMOLLING J
WAGNER U
REINSBERG J
BIERSACK HJ
KREBS D
Citation: J. Schmolling et al., IMMUNOLOGICAL AND CLINICAL-RESPONSE OF OV ARIAN-CARCINOMA PATIENTS AFTER TREATMENT WITH (131)J-F(AB)(2) OC-125 MAB, Geburtshilfe und Frauenheilkunde, 55(4), 1995, pp. 200-203
Authors:
REINSBERG J
GAST B
SCHMOLLING J
WAGNER U
KREBS D
Citation: J. Reinsberg et al., SPECIFIC INTERFERENCE WITH THE DETERMINATION OF THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 BY HUMAN ANTIIDIOTYPIC ANTIBODIES FORMED AFTER TREATMENT WITH THE ANTI-TUMOR-ASSOCIATED GLYCOPROTEIN-72 ANTIBODY B72.3, European journal of clinical chemistry and clinical biochemistry, 32(9), 1994, pp. 691-696
Citation: J. Reinsberg et al., FALSE CHANGES IN CA-125 LEVELS IN OVARIAN-CANCER PATIENTS AFTER INFUSION OF OC125 FRAGMENTS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSE, Archives of gynecology and obstetrics, 255(1), 1994, pp. 9-18
Citation: J. Reinsberg et B. Gast, HUMAN ANTIIDIOTYPIC ANTIBODIES AGAINST OC125 STRONGLY INTERFERE WITH ONE-STEP ASSAYS OF CA-125 EMPLOYING OC125 AND M11 ANTIBODIES, Clinical chemistry, 40(6), 1994, pp. 951-952
Authors:
SCHULTES BC
REINSBERG J
SCHLEBUSCH H
OEHR P
BIERSACK HJ
KREBS D
WAGNER U
Citation: Bc. Schultes et al., IDIOTYPIC CASCADES AFTER INJECTION OF THE MONOCLONAL-ANTIBODY OC125 -A STUDY IN A MOUSE MODEL - INDUCTION OF ANTIBODIES AGAINST OC125 AND CA-125 AFTER IMMUNIZATION WITH AN ANTI-CA-125 (MAB OC125) MONOCLONAL-ANTIBODY BY ACTIVATION OF THE IDIOTYPIC NETWORK, European journal of clinical chemistry and clinical biochemistry, 31(7), 1993, pp. 427-432
Citation: J. Reinsberg et W. Nocke, FALSELY LOW RESULTS IN CA-125 DETERMINATION DUE TO ANTIIDIOTYPIC ANTIBODIES INDUCED BY INFUSION OF [I-131] F(AB')(2) FRAGMENTS OF THE OC125ANTIBODY, European journal of clinical chemistry and clinical biochemistry, 31(5), 1993, pp. 323-327
Authors:
WAGNER U
SCHMOLLING J
REINSBERG J
KREBS D
Citation: U. Wagner et al., IDIOTYPIC NETWORK ACTIVATION BY TREATMENT WITH THE MONOCLONAL-ANTIBODY OC125 AS IMMUNOTHERAPY FOR OVARIAN-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1093-1095
Citation: J. Reinsberg et al., ANTIBODY INDUCTION VIA OC125 FRAGMENTS AN D ITS SIGNIFICANCE FOR CA125 DETECTION, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1095-1097
Authors:
SCHMOLLING J
REINSBERG J
WAGNER U
KREBS D
Citation: J. Schmolling et al., DYNAMICS OF THE FORMATION OF ANTIIDIOTYPI C ANTIBODIES AND EFFECTS ONCA125 LEVELS FOLLOWING IDIOTYPIC VACCINATION WITH MAB OC125 IN OVARIAN-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1097-1099
Authors:
WAGNER U
CHRONIDES A
MALLMANN P
REINSBERG J
SCHULTES B
CUI H
LIU Q
OEHR P
SCHMOLLING J
SCHLEBUSCH H
SCHMIDT S
BIERSACK HJ
KREBS D
Citation: U. Wagner et al., INDUCTION OF A TUMOR-SPECIFIC CELLULAR-IM MUNITY BY IDIOTYPE-VACCINATION WITH THE MAB OC 125 FOR PATIENTS WITH OVARIAN CARCINOMAS, Tumordiagnostik & Therapie, 14(4), 1993, pp. 125-131
Citation: J. Reinsberg et al., MONITORING CANCER ANTIGEN-125 IN SERUM OF OVARIAN-CANCER PATIENTS AFTER ADMINISTRATION OF I-131-LABELED F(AB')2 FRAGMENTS OF OC125 ANTIBODY, Clinical chemistry, 39(5), 1993, pp. 891-896